Brad Niles, PhD
Chief Executive Officer
20 years experience in cancer research and product development
Glenn Kazo
Chief Business Officer
Founder of Enzon, inventor of Pegylation technology. Had a leading role in 3 IPOs and raised over $500M
Lonnie Bookbinder, PhD, MBA
Board Chairman
Leadership in pharma industry, drug licensing to pharma, serial entrepreneur, 47 years in industry
Mark Kester, PhD
Scientific Advisor
Director of Nanotech Center & Pharmacology Professor at U. VA, Drug Delivery Systems; co-founder Keystone Nano
Narendra Vaish, PhD
Scientific Advisor
Expert in RNA Inhibition and siRNA drug design with >100 biomed patent applications
Sundeep Dugar, PhD Scientific Advisor >30 years in drug development (Scios, J&J, BMS, Schering-
Plough, Sphaera Pharma, Epirium Bio)
Shi Huang, PhD Scientific Advisor Discoverer or PRDM family, Professor at Central South University, China
Lokesh Sikaria Board Member Founder and Managing Director at Moneta Ventures Kevin Nagle Board Member Investor, co-Founder of EnvisionRx Options, former Upjohn executive, co-Owner of Sacramento Kings (NBA) and Sac Republic FC (MLS)
Sabya Das Board Member Partner at Moneta Ventures